Chitosan derivative nanocarrier: safety evaluation,antibacterial property and ascorbyl palmitate encapsulation.
暂无分享,去创建一个
T. Palaga | S. Rengpipat | P. Asawanonda | Mayura Wittayasuporn | Nattaporn Anumansirikul | S. Wanichwecharungruang
[1] Cecilia Díaz,et al. Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines. , 2006, International journal of pharmaceutics.
[2] S. Wanichwecharungruang,et al. UV-screening chitosan nanocontainers: increasing the photostability of encapsulated materials and controlled release , 2008, Nanotechnology.
[3] R. Tharanathan,et al. Chitin/chitosan: modifications and their unlimited application potential—an overview , 2007 .
[4] In-Yong Kim,et al. Chitosan and its derivatives for tissue engineering applications. , 2008, Biotechnology advances.
[5] Y. Ohya,et al. Preparation of PEG-grafted chitosan nanoparticles as peptide drug carriers , 2003 .
[6] O. Smidsrod,et al. In vitro degradation rates of partially N-acetylated chitosans in human serum. , 1997, Carbohydrate research.
[7] Chiing-Chang Chen,et al. Relationship between antibacterial activity of chitosan and surface characteristics of cell wall. , 2004, Acta pharmacologica Sinica.
[8] Chih-Yu Chen,et al. Antibacterial characteristics and activity of acid-soluble chitosan. , 2008, Bioresource technology.
[9] Yingchien Chung,et al. Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens. , 2003, Bioresource technology.
[10] Hyeon Gyu Lee,et al. Stability of chitosan nanoparticles for L-ascorbic acid during heat treatment in aqueous solution. , 2008, Journal of agricultural and food chemistry.
[11] J. Gao,et al. Safety evaluation of short-term exposure to chitooligomers from enzymic preparation. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[12] O. Smidsrod,et al. Chemical composition of O-(carboxymethyl)-chitins in relation to lysozyme degradation rates , 1997 .
[13] T. Cheng,et al. Therapeutic potential of chitosan and its derivatives in regenerative medicine. , 2006, The Journal of surgical research.
[14] S. Davis,et al. Chitosan as a novel nasal delivery system for vaccines. , 2001, Advanced drug delivery reviews.
[15] Zi-rong Xu,et al. Preparation and antibacterial activity of chitosan nanoparticles. , 2004, Carbohydrate research.
[16] J. Kristl,et al. Effect of colloidal carriers on ascorbyl palmitate stability. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] V. Kmetec,et al. Stability of ascorbyl palmitate in topical microemulsions. , 2001, International journal of pharmaceutics.
[18] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate. , 2005, Die Pharmazie.
[19] K. Yao,et al. A chitosan-arginine conjugate as a novel anticoagulation biomaterial , 2004, Journal of materials science. Materials in medicine.
[20] U. Bakowsky,et al. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.
[21] K. Leong,et al. Chitosan‐g‐PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions , 2006, The journal of gene medicine.